← Leaderboards
Todd Adam Florin
Lurie Children'S Hospital Of Chicago
$5,530,492
Attributed
$5,530,492
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,530,492 · 4
By mechanism
R01$3,862,565 · 1
R34$750,009 · 1
K23$742,541 · 1
R03$175,377 · 1
Top collaborators
No co-investigators on record.
Most similar at Lurie Children'S Hospital Of Chicago
Same institution · by research overlap
- Valerie L Durkalski$19,943,358
- Nia Jenee' Heard-Garris$1,674,191
- Elan Hope$788,591
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionChildChildhoodBiological MarkersProcalcitoninAdultPneumoniaClinical RiskEvidence BaseDeteriorationResourcesGuidelines18 Year OldDisease ProgressionOutpatientsDiagnostic TestsSeveritiesEnrollmentHigh RiskHospitalizationMultidisciplinaryAccident And Emergency DepartmentSeverity Of IllnessUnited States
Grant awards (12)
Derivation and Validation of the Pediatric Community-Acquired Pneumonia Severity (PedCAPS) Score$1,594,811
R01 · FY2025 · HL · contact PI
Derivation and Validation of the Pediatric Community-Acquired Pneumonia Severity (PedCAPS) Score$1,182,683
R01 · FY2024 · HL · contact PI
Derivation and Validation of the Pediatric Community-Acquired Pneumonia Severity (PedCAPS) Score$1,085,071
R01 · FY2023 · HL · contact PI
Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia (P-RAPP)$353,127
R34 · FY2021 · HL · contact PI
Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia (P-RAPP)$396,882
R34 · FY2020 · HL · contact PI
Urinary Proadrenomedullin to Improve Risk Stratification of Children with Community-Acquired Pneumonia$78,810
R03 · FY2020 · AI · contact PI
BIOMARKERS AND RISK STRATIFICATION IN PEDIATRIC COMMUNITY-ACQUIRED PNEUMONIA$189,049
K23 · FY2019 · AI · contact PI
Urinary Proadrenomedullin to Improve Risk Stratification of Children with Community-Acquired Pneumonia$96,567
R03 · FY2019 · AI · contact PI
Biomarkers and Risk Stratification in Pediatric Community-Acquired Pneumonia$105,485
K23 · FY2018 · AI · contact PI
BIOMARKERS AND RISK STRATIFICATION IN PEDIATRIC COMMUNITY-ACQUIRED PNEUMONIA$83,531
K23 · FY2018 · AI · contact PI
Biomarkers and Risk Stratification in Pediatric Community-Acquired Pneumonia$188,977
K23 · FY2017 · AI · contact PI
Biomarkers and Risk Stratification in Pediatric Community-Acquired Pneumonia$175,499
K23 · FY2016 · AI · contact PI